StockData

China Pharma Holdings, Inc. (CPHI) income statement

CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.52−0.04 (-7.47%)

Close on Nov 13, 2026Market cap $22.29MP/E –Yield –

China Pharma Holdings, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
11.8%
Operating margin
-111.8%
Net margin
-114.3%
Return on equity, FY2025
-20.9%

Financial strength

Current ratio
0.26
Debt to equity
–
Debt to assets
–
Cash to current liabilities
4.0%

Valuation

P/E ratio
–
Price to sales
5.69
Price to book
0.62
Dividend yield
–

See a number that looks wrong?